@inproceedings{inproceedings, title  = {{Non-inferiority of oral ibandronate to intravenous zoledronic acid for reducing markers of bone turnover in metastatic breast cancer patients}},

 url = {{}},

 year = {{2005}},

 month = {{1}},

 author = {{Lichinitser MR and Coleman RE and Tjulandin SA and Bergstrom B and Body JJ}},

 volume = {{94}},

 journal = {{BREAST CANCER RESEARCH AND TREATMENT}},

 pages = {{S259-S259}},

 note = {{Accessed on 2025/10/10}}}